BioSpace News Archive

Pioneering scientists at VIB, the University of Copenhagen, DKFZ, and Stanford University are the first to deploy systems that deliver highest-resolution view of subcellular gene expression activity.

Four abstracts accepted of Phase 3 data from PEDFIC 1 and PEDFIC 2 trials of Bylvay™ (odevixibat) .

Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that it has not yet received a decision from the U.S. Food and Drug Administration (FDA) on its 505(b)(2) New Drug Application (NDA) for ACER-001.

Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“ Clearmind ” or the " company "), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced positive pre-clinical results for its treatment for cocaine addiction.

Transdermal and transmucosal drug delivery systems as alternative drug delivery routes have gained traction in clinical practices over the past few decades.

Sanofi launches Action 2022, its global employee share ownership plan, open to 86 000 employees in 59 countries.

Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates for the treatment of cancers with high unmet needs, announces the appointment of Hatem Azim, MD, PhD, as Chief Medical Officer, as of 6 June 2022.

Royal Philips announced that the exchange ratio for the dividend in shares for the year 2021 has been determined.

RARE-X announced that through the development of its new “The Power of Being Counted” Report, it has discovered that there are as many as 10,867 rare diseases, rather than the oft-reported previous estimate of 5,000-8,000.

Henry Schein, Inc., the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced that it has signed a definitive agreement to acquire Condor Dental Research Company SA, a privately held dental distribution company that serves dental general practitioners, specialists, and laboratories in Switzerland.